Fulgent Genetics

📍 El Monte, United States🗓 Founded 2011👥 407 employees💰 Last funded Dec 2018
Our mission is to develop flexible and affordable diagnostics and therapeutics that improve the everyday lives of those around us. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike. - Our Products & Services - Fulgent Genetics https://www.fulgentgenetics.com/ Fulgent Oncology https://fulgentoncology.com/ Fulgent BioPharma https://biopharma.fulgent.com/ Picture Genetics https://picturegenetics.com/ HelioLiver https://www.helioliver.com/ Fulgent is a CLIA-certified and CAP-accredited laboratory. _____________ NASDAQ: FLGT
4
Total investors
0
Early stage
0
Mid stage
4
Late stage
2011
Founded
Investor geography1 country
United States
4
Investor activity2017–2018 · investors recorded per year
2017320181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Fulgent Genetics?
Fulgent Genetics has 4 investors on record on gritt.io and 4 late-stage investors.
When did Fulgent Genetics last raise funding?
The most recent investment in Fulgent Genetics recorded on gritt.io was in December 2018.
When was Fulgent Genetics founded?
Fulgent Genetics was founded in 2011.
What industry is Fulgent Genetics in?
Fulgent Genetics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Fulgent Genetics based?
Fulgent Genetics is headquartered in El Monte, United States.